Log in to save to my catalogue

Acetazolamide modulates intracranial pressure directly by its action on the cerebrospinal fluid secr...

Acetazolamide modulates intracranial pressure directly by its action on the cerebrospinal fluid secr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2619062236

Acetazolamide modulates intracranial pressure directly by its action on the cerebrospinal fluid secretion apparatus

About this item

Full title

Acetazolamide modulates intracranial pressure directly by its action on the cerebrospinal fluid secretion apparatus

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2022-01

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Elevated intracranial pressure (ICP) is observed in many neurological pathologies, e.g. hydrocephalus and stroke. This condition is routinely relieved with neurosurgical approaches, since effective and targeted pharmacological tools are still lacking. The carbonic anhydrase inhibitor, acetazolamide (AZE), may be employed to treat elevated ICP. Howe...

Alternative Titles

Full title

Acetazolamide modulates intracranial pressure directly by its action on the cerebrospinal fluid secretion apparatus

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2619062236

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2619062236

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2022.01.11.475854